HRP20151422T1 - Postupak za pripremu estera (5-fluoro-2-metil-3-hinolin-2-ilmetil-indol-1-il)-octene kiseline - Google Patents

Postupak za pripremu estera (5-fluoro-2-metil-3-hinolin-2-ilmetil-indol-1-il)-octene kiseline Download PDF

Info

Publication number
HRP20151422T1
HRP20151422T1 HRP20151422TT HRP20151422T HRP20151422T1 HR P20151422 T1 HRP20151422 T1 HR P20151422T1 HR P20151422T T HRP20151422T T HR P20151422TT HR P20151422 T HRP20151422 T HR P20151422T HR P20151422 T1 HRP20151422 T1 HR P20151422T1
Authority
HR
Croatia
Prior art keywords
formula
compound
process according
iii
reaction
Prior art date
Application number
HRP20151422TT
Other languages
English (en)
Croatian (hr)
Inventor
Jacques Tonnel
Tony Pintus
Alain Burgos
Original Assignee
Atopix Therapeutics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atopix Therapeutics Limited filed Critical Atopix Therapeutics Limited
Publication of HRP20151422T1 publication Critical patent/HRP20151422T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HRP20151422TT 2011-12-15 2012-12-14 Postupak za pripremu estera (5-fluoro-2-metil-3-hinolin-2-ilmetil-indol-1-il)-octene kiseline HRP20151422T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201121557A GB201121557D0 (en) 2011-12-15 2011-12-15 Process
PCT/GB2012/000903 WO2013088108A1 (en) 2011-12-15 2012-12-14 Process for the preparation of (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid esters
EP12805725.4A EP2791129B1 (en) 2011-12-15 2012-12-14 Process for the preparation of (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid esters

Publications (1)

Publication Number Publication Date
HRP20151422T1 true HRP20151422T1 (hr) 2016-02-26

Family

ID=45560499

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20151422TT HRP20151422T1 (hr) 2011-12-15 2012-12-14 Postupak za pripremu estera (5-fluoro-2-metil-3-hinolin-2-ilmetil-indol-1-il)-octene kiseline

Country Status (27)

Country Link
US (1) US9102658B2 (https=)
EP (1) EP2791129B1 (https=)
JP (2) JP6300277B2 (https=)
KR (1) KR102018929B1 (https=)
CN (1) CN104114548B (https=)
AU (1) AU2012351341B2 (https=)
BR (1) BR112014014604B1 (https=)
CA (1) CA2859281C (https=)
CY (1) CY1117087T1 (https=)
DK (1) DK2791129T3 (https=)
EA (1) EA026617B1 (https=)
ES (1) ES2557762T3 (https=)
GB (1) GB201121557D0 (https=)
HR (1) HRP20151422T1 (https=)
HU (1) HUE028257T2 (https=)
IL (1) IL233132A (https=)
ME (1) ME02348B (https=)
MX (1) MX342273B (https=)
PL (1) PL2791129T3 (https=)
PT (1) PT2791129E (https=)
RS (1) RS54523B1 (https=)
SG (1) SG11201402798RA (https=)
SI (1) SI2791129T1 (https=)
SM (1) SMT201500327B (https=)
UA (1) UA111868C2 (https=)
WO (1) WO2013088108A1 (https=)
ZA (1) ZA201404246B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201103837D0 (en) 2011-03-07 2011-04-20 Oxagen Ltd Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid
GB201121557D0 (en) * 2011-12-15 2012-01-25 Oxagen Ltd Process
GB201322273D0 (en) * 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
US20220184060A1 (en) 2018-12-27 2022-06-16 Chiesi Farmaceutici S.P.A. Pharmaceutical composition comprising spherical agglomerates of timapiprant
CN111978245A (zh) * 2020-09-15 2020-11-24 上海毕得医药科技有限公司 一种3-氟-2-异丁基吡啶的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004283139A1 (en) 2003-10-14 2005-05-06 Oxagen Limited Compounds having CRTH2 antagonist activity
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
GB0504150D0 (en) * 2005-03-01 2005-04-06 Oxagen Ltd Microcrystalline material
GB0505048D0 (en) 2005-03-11 2005-04-20 Oxagen Ltd Compounds with PGD antagonist activity
US7188489B2 (en) 2005-04-12 2007-03-13 Martello Russell A Portable air conditioner
GB0605743D0 (en) 2006-03-22 2006-05-03 Oxagen Ltd Salts with CRTH2 antagonist activity
US7999119B2 (en) 2006-07-22 2011-08-16 Oxagen Limited Compounds having CRTH2 antagonist activity
US20110124683A1 (en) 2007-11-13 2011-05-26 Oxagen Limited Use of CRTH2 Antagonist Compounds
AU2009204700B2 (en) 2008-01-18 2013-07-04 Atopix Therapeutics Limited Compounds having CRTH2 antagonist activity
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
JP2011509991A (ja) 2008-01-22 2011-03-31 オキサジェン リミテッド Crth2アンタゴニスト活性を有する化合物
EP2265581A1 (en) 2008-01-22 2010-12-29 Oxagen Limited Compounds having crth2 antagonist activity
US20130052190A1 (en) 2011-02-22 2013-02-28 Oxagen Limited CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Conditions
GB201103837D0 (en) 2011-03-07 2011-04-20 Oxagen Ltd Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid
GB201121557D0 (en) 2011-12-15 2012-01-25 Oxagen Ltd Process
EP2790696A1 (en) 2011-12-16 2014-10-22 Atopix Therapeutics Limited Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis

Also Published As

Publication number Publication date
EA201490998A1 (ru) 2014-11-28
KR102018929B1 (ko) 2019-09-05
SG11201402798RA (en) 2014-06-27
BR112014014604A2 (pt) 2017-06-13
DK2791129T3 (en) 2015-12-14
JP2015500325A (ja) 2015-01-05
JP6300277B2 (ja) 2018-03-28
GB201121557D0 (en) 2012-01-25
MX2014007129A (es) 2014-09-04
BR112014014604B1 (pt) 2021-01-12
PL2791129T3 (pl) 2016-05-31
KR20140113927A (ko) 2014-09-25
EA026617B1 (ru) 2017-04-28
SMT201500327B (it) 2016-02-25
RS54523B1 (sr) 2016-06-30
HUE028257T2 (en) 2016-12-28
EP2791129A1 (en) 2014-10-22
CY1117087T1 (el) 2017-04-05
US9102658B2 (en) 2015-08-11
AU2012351341B2 (en) 2017-08-24
EP2791129B1 (en) 2015-10-07
CN104114548A (zh) 2014-10-22
MX342273B (es) 2016-09-21
AU2012351341A1 (en) 2014-07-24
PT2791129E (pt) 2016-01-26
ES2557762T3 (es) 2016-01-28
CN104114548B (zh) 2016-01-20
ME02348B (me) 2016-06-20
JP2018008985A (ja) 2018-01-18
NZ626732A (en) 2015-09-25
CA2859281C (en) 2020-10-27
WO2013088108A1 (en) 2013-06-20
IL233132A (en) 2015-09-24
UA111868C2 (uk) 2016-06-24
IL233132A0 (en) 2014-08-03
HK1197671A1 (zh) 2015-02-06
SI2791129T1 (sl) 2016-02-29
US20140350264A1 (en) 2014-11-27
CA2859281A1 (en) 2013-06-20
ZA201404246B (en) 2016-10-26

Similar Documents

Publication Publication Date Title
HRP20151422T1 (hr) Postupak za pripremu estera (5-fluoro-2-metil-3-hinolin-2-ilmetil-indol-1-il)-octene kiseline
UA102386C2 (ru) Способ получения алкил-2-алкоксимэтилен-4,4-дифтор-3-оксобутиратов
HRP20160241T1 (hr) Postupci i intermedijeri za pripravu jak inhibitora
CN102603607A (zh) (r)-奥拉西坦的制备方法
HRP20220201T1 (hr) Postupak za pripremu pleuromutilina
RU2011129249A (ru) Способ получения метакрилированных бензофенонов
HRP20140431T1 (hr) Postupak za jodiranje aromatskih tvari
CN103274959B (zh) 一种凉味剂n,2,3-三甲基-2-异丙基丁酰胺的合成方法
MX2014006249A (es) Metodo para producir y purificar sales del acido acrilamido - 2 - metilpropan sulfonico.
MX2020010367A (es) Procedimiento para la preparación de iopamidol.
JP2015500325A5 (https=)
HRP20120958T1 (hr) Postupci za pripremanje supstituirane gama-aminokiseline
CN106496038A (zh) 一种高选择性的3‑甲基‑2‑硝基苯甲酸的制备方法
HRP20151432T1 (hr) Postupak za dobivanje nebivolola
CN101182342A (zh) 1,2,3-o-三-乙酰基-5-脱氧-d-核糖的合成方法
WO2016024284A2 (en) A process for the preparation of mirabegron and its intermediates
CN102060797A (zh) 一种高纯度缬沙坦甲酯晶体的生产工艺
ES2836118T3 (es) Procedimiento para la preparación de un análogo de prostaglandina donante de óxido nítrico
HRP20110322T1 (hr) Postupak za pročišćavanje montelukasta
FR2921565B1 (fr) Procede de recuperation d'acides fluorocarboxyliques
HRP20120501T1 (hr) Postupak proizvodnje 4'-[[4-metil-6-(1-metil-1h-benzimidazol-2-il)-2-propil-1h-benzimidazol-1-il]metil]bifenil-2-karboksilne kiseline (telmisartan)
IN2013MN02407A (https=)
KR20150091150A (ko) 트라보프로스트의 제조 방법
HRP20160407T1 (hr) Postupak za pripravu skopin estera di-(2-tienil) glikolne kiseline, međuprodukta u sintezi tiotropij bromida
CN103044361B (zh) 一种(2r,3s)-环氧化氨基苯丁烷的制备方法